Arcutis biotherapeutics stock.
Arcutis Biotherapeutics reported an EPS of -$0.73 in its last earnings report, beating expectations of -$0.914. Following the earnings report the stock price went up 9.91%. Which hedge fund is a major shareholder of Arcutis Biotherapeutics?
Nov 28, 2023 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for ARQT stock stock is $33.38, which predicts an increase of 1,268.03%. The lowest target is $4.00 and the highest is $50. On average, analysts rate ARQT stock stock as a strong buy. The latest price target for Arcutis Biotherapeutics ( NASDAQ: ARQT) was reported by Morgan Stanley on Monday, November 13, 2023. The analyst firm set a price target for 10.00 expecting ARQT to ...February 28, 2023 at 4:02 PM · 11 min read. Arcutis Biotherapeutics, Inc. Achieved net revenues of $3.0 million for ZORYVE® (roflumilast) cream 0.3% in the first full quarter since the August ...Nov 9, 2023 · Arcutis Biotherapeutics (NASDAQ:ARQT) Third Quarter 2023 ResultsKey Financial Results. Revenue: US$38.1m (up by US$37.4m from 3Q 2022). Net loss: US$44.8m (loss narrowed by 58% from 3Q 2022).
Arcutis Announces Pricing of $100 Million Public Offering. WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage biopharmaceutical company focused on developing meaningf... 4 weeks ago - GlobeNewsWire.
Get the latest Arcutis Biotherapeutics, Inc. (ARQT) stock news and headlines to help you in your trading and investing decisions. ... Nov. 29, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc ...
Sean Kim PhD, an analyst from JonesTrading, reiterated the Buy rating on Arcutis Biotherapeutics (ARQT – Research Report). The associated price target is $44.00. The associated price target is ...The stock options have a ten-year term and an exercise price of $7.65 per share, equal to the per share closing price of Arcutis’ common stock as reported by Nasdaq on June 1, 2023. Arcutis is ...As of September 1, 2023, Arcutis Biotherapeutics Inc’s stock price is $8.96, which is up 4.92% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and ...At Arcutis, we fiercely value people—our patients, healthcare providers, team members, and our community at large. We aspire to be an upstanding global figure, with strong ethical standards embedded in our culture, and guiding our actions. We are a Great Place to Work ® -Certified company, a 2022 Fortune Best Workplaces in Biopharma™, and ...These 8 analysts have an average price target of $25.62 versus the current price of Arcutis Biotherapeutics at $2.49, implying upside. Below is a summary of how these 8 analysts rated Arcutis ...
FDA Accepts Arcutis' Supplemental New Drug Application for Roflumilast Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to Age 6.
1.9900. +0.1500. +8.15%. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript November 3, 2023 Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is ...
Shares of Arcutis Biotherapeutics ... The healthcare company's stock closed last week at $8.96 a share and fell to as low as $7.47 on Thursday after Arcutis reported trial data regarding a ...In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of Arcutis’ common stock at the public offering price less the underwriting discounts and commissions. ... Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of patients living with immune-mediated ...Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Arcutis has a growing …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Meaningful innovation at a glance. Download our corporate fact sheet. Download. Learn how Arcutis is advancing the treatment of immune-mediated skin …Mar 9, 2021 · The Arcutis Biotherapeutics stock prediction for 2025 is currently $ 1.777134, assuming that Arcutis Biotherapeutics shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -12.46% increase in the ARQT stock price.
Aug 3, 2022 · In addition, Arcutis has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the public offering price, less underwriting discounts and ... Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | 16,482 followers on LinkedIn. Bioscience, applied to the skin. | Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant …Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | 16,482 followers on LinkedIn. Bioscience, applied to the skin. | Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant …Arcutis Biotherapeutics Inc ARQT. Arcutis Biotherapeutics announced the pricing of a $100 million public offering of 32.5 million common shares at $2.50 per share. The company has a 52-week low of ...Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong …According to 6 analyst offering 12-month price targets in the last 3 months, Arcutis Biotherapeutics has an average price target of $42.17 with a high of $57.00 and a low of $22.00.Dec 1, 2023 · 9 analysts have issued twelve-month target prices for Arcutis Biotherapeutics' shares. Their ARQT share price targets range from $6.00 to $57.00. On average, they anticipate the company's stock price to reach $29.67 in the next year. This suggests a possible upside of 1,390.8% from the stock's current price.
Arcutis Biotherapeutics Stock Forecast, ARQT stock price prediction. Price target in 14 days: 2.559 USD. The best long-term & short-term Arcutis ...
Latest News. November 15, 2022. Get Arcutis Biotherapeutics Inc (ARQT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.As of September 1, 2023, Arcutis Biotherapeutics Inc’s stock price is $8.96, which is up 4.92% from its previous closing price. At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and ...Jun 9, 2023 · Shares of Arcutis Biotherapeutics ( ARQT -3.16%) climbed 21.2% for the week after rising as high as 23.8%, according to data provided by S&P Global Market Intelligence. The medical dermatology ... The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.The Investor Relations website contains information about Arcutis Biotherapeutics's business for stockholders, potential investors, and financial analysts. Arcutis Biotherapeutics Stock Performance. ARQT opened at $2.34 on Monday. Arcutis Biotherapeutics has a 52-week low of $2.13 and a 52-week high of $20.11. The firm has a market capitalization of ...Sep 25, 2023 · According to 6 analyst offering 12-month price targets in the last 3 months, Arcutis Biotherapeutics has an average price target of $42.17 with a high of $57.00 and a low of $22.00.
The stock options have a ten-year term and an exercise price of $1.99 per share, equal to the per share closing price of Arcutis’ common stock as reported by …
Oct 9, 2023 · Sean Kim PhD, an analyst from JonesTrading, reiterated the Buy rating on Arcutis Biotherapeutics (ARQT – Research Report). The associated price target is $44.00. The associated price target is ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.WESTLAKE VILLAGE, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported financial results for the quarter ended March 31, 2023, and provided a business …One company hoping for such success is Arcutis Biotherapeutics (ARQT 4.08%). It has been developing a treatment for Seborrheic dermatitis -- a skin disorder that causes scaly skin, or dandruff ...1.9900. +0.1500. +8.15%. Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q3 2023 Earnings Call Transcript November 3, 2023 Arcutis Biotherapeutics, Inc. beats earnings expectations. Reported EPS is ...About Arcutis Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Arcutis …Arcutis is building momentum around its Zoryve segment with a string of recent advancements at the back end of FY22 and into the new year. Find out why ARQT stock is a Buy.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...As of March 10, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $12.09. Arcutis Biotherapeutics Inc is down 5.03% from its previous closing price of $12.73. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $12.06 and $13.57. Currently, there are 61.04 million shares of Arcutis ...Arcutis Biotherapeutics Stock Performance. ARQT opened at $2.34 on Monday. Arcutis Biotherapeutics has a 52-week low of $2.13 and a 52-week high of $20.11. The firm has a market capitalization of ...Arcutis Biotherapeutics Revenues and Earnings Beat Expectations. Revenue exceeded analyst estimates by 24%. Earnings per share (EPS) also surpassed analyst estimates by 17%. Looking ahead, revenue ...Arcutis Biotherapeutics Stock Price, News & Analysis (NASDAQ:ARQT) $1.99 +0.15 (+8.15%) (As of 12/1/2023 ET) Compare Today's Range $1.76 $2.00 50-Day …
In the last 3 months, 7 analysts have offered 12-month price targets for Arcutis Biotherapeutics. The company has an average price target of $38.14 with a high of $57.00 and a low of $22.00.August 8, 2023 at 4:02 PM · 11 min read. Arcutis Biotherapeutics, Inc. Achieved total revenues of $5.2 million in the second quarter of 2023. Net product revenues for ZORYVE® (roflumilast) cream ...Arcutis Biotherapeutics reported an EPS of -$0.73 in its last earnings report, beating expectations of -$0.914. Following the earnings report the stock price went up 9.91%. Which hedge fund is a major shareholder of Arcutis Biotherapeutics? Instagram:https://instagram. vivid seats fees calculatordautche bankautop zoneashton kutcher investment WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (“Arcutis”) (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the pricing of its underwritten public offering of 7,500,000 shares of its common stock ... most popular dog breed 2023step energy services ltd. ARCUTIS BIOTHERAPEUTICS, INC. Condensed Balance Sheets (In thousands) March 31, December 31, 2023 2022 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 81,405 $ 53,641 Restricted cash 925 1,234 Trade receivable, net 12,769 8,458 Marketable securities 251,000 355,948 Inventories 8,551The latest price target for Arcutis Biotherapeutics ( NASDAQ: ARQT) was reported by Morgan Stanley on Monday, November 13, 2023. The analyst firm set a price target for 10.00 expecting ARQT to ... mon ceur The stock of Arcutis Biotherapeutics Inc (ARQT) has seen a -2.21% decrease in the past week, with a -15.82% drop in the past month, and a -75.12% decrease in the past quarter. The volatility ratio for the week is 13.81%, and the volatility levels for the past 30 days are at 11.73% for ARQT. The simple moving average for the last 20 days is …Track Arcutis Biotherapeutics Inc (ARQT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsArcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated ...